These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 6707719)
1. Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study. Quagliana JM; Stephens RL; Baker LH; Costanzi JJ J Clin Oncol; 1984 Apr; 2(4):316-9. PubMed ID: 6707719 [TBL] [Abstract][Full Text] [Related]
2. Vindesine for metastatic malignant melanoma. A phase II trial. Nelimark RA; Peterson BA; Vosika GJ; Conroy JA Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921 [TBL] [Abstract][Full Text] [Related]
3. [Pilot study with vindesine as monotherapy in metastatic malignant melanomas]. Balda BR; Jehn U; Klövekorn W; Wohlrab A MMW Munch Med Wochenschr; 1983 Jan; 125(3):54-6. PubMed ID: 6402675 [No Abstract] [Full Text] [Related]
4. Broad phase II study of vindesine. Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021 [TBL] [Abstract][Full Text] [Related]
5. Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma. Mayol XF; Beltran J; Rubio-Bazan R; Rifa J; Costa RR; Lopez JJ Cancer Treat Rep; 1984 Sep; 68(9):1199-200. PubMed ID: 6444204 [No Abstract] [Full Text] [Related]
6. A multicentre phase II trial of vindesine in malignant melanoma. Carmichael J; Atkinson RJ; Calman KC; Mackie RM; Naysmith AM; Smyth JF Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1293-5. PubMed ID: 6891927 [TBL] [Abstract][Full Text] [Related]
7. Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin. Pectasides D; Yianniotis H; Alevizakos N; Bafaloukos D; Barbounis V; Varthalitis J; Dimitriadis M; Athanassiou A Br J Cancer; 1989 Oct; 60(4):627-9. PubMed ID: 2803936 [TBL] [Abstract][Full Text] [Related]
8. Vindesine in bronchogenic carcinoma: a phase II trial. Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107 [TBL] [Abstract][Full Text] [Related]
9. Vindesine in advanced breast cancer, lymphoma and melanoma. A Colorado Clinical Oncology Group study. DiBella NJ; Berris R; Garfield D; Fink K; Speer J; Sakamoto A Invest New Drugs; 1984; 2(3):323-8. PubMed ID: 6511238 [TBL] [Abstract][Full Text] [Related]
10. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung. Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108 [TBL] [Abstract][Full Text] [Related]
11. A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study. Whitehead RP; Moon J; McCachren SS; Hersh EM; Samlowski WE; Beck JT; Tchekmedyian NS; Sondak VK; Cancer; 2004 Apr; 100(8):1699-704. PubMed ID: 15073859 [TBL] [Abstract][Full Text] [Related]
12. Vindesine as a single agent in the treatment of advanced malignant melanoma. Retsas S; Newton KA; Westbury G Cancer Chemother Pharmacol; 1979; 2(4):257-60. PubMed ID: 455584 [TBL] [Abstract][Full Text] [Related]
13. Vindesine: an effective agent in the treatment of non-small cell lung cancer. Furnas BE; Williams SD; Einhorn LH; Cobleigh MA Cancer Treat Rep; 1982 Sep; 66(9):1709-11. PubMed ID: 7116347 [TBL] [Abstract][Full Text] [Related]
14. Phase II study of vindesine in patients with metastatic breast cancer. Cobleigh MA; Williams SD; Einhorn LH Cancer Treat Rep; 1981; 65(7-8):659-63. PubMed ID: 7248983 [TBL] [Abstract][Full Text] [Related]
15. Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II study. Mulder JH; Dodion P; Cavalli F; Czarnetzki B; Clavel M; Thomas D; Suciu S; Rozencweig M Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1297-301. PubMed ID: 6891928 [TBL] [Abstract][Full Text] [Related]
16. Phase II study of vindesine in metastatic malignant melanoma. Arseneau JC; Mellette SJ; Kuperminc M; Wolter J Cancer Treat Rep; 1981; 65(3-4):355-6. PubMed ID: 7237458 [No Abstract] [Full Text] [Related]
17. Phase II study of vindesine sulfate in the therapy for advanced renal carcinoma. Wong PP; Yagoda A; Currie VE; Young CW Cancer Treat Rep; 1977 Dec; 61(9):1727-9. PubMed ID: 340038 [No Abstract] [Full Text] [Related]
18. Detorubicin--an active anthracycline in untreated metastatic melanoma. Chawla SP; Legha SS; Benjamin RS J Clin Oncol; 1985 Nov; 3(11):1529-34. PubMed ID: 4056844 [TBL] [Abstract][Full Text] [Related]
19. [Phase II study of vindesine in hematological malignancies]. Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841 [TBL] [Abstract][Full Text] [Related]
20. Phase-II study of Navelbine in advanced breast cancer. Canobbio L; Boccardo F; Pastorino G; Brema F; Martini C; Resasco M; Santi L Semin Oncol; 1989 Apr; 16(2 Suppl 4):33-6. PubMed ID: 2711204 [No Abstract] [Full Text] [Related] [Next] [New Search]